Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Breast Cancer Research and Treatment|October 21, 2010
Germline mutations in BRCA1 and BRCA2 genes in ethnically diverse high risk families in IsraelYael Laitman, Roni Tsipora Borsthein, Dominique Stoppa-Lyonnet, et al.
JAMA Oncology|August 7, 2015
Breast Cancer Diagnosed During Pregnancy: Adapting Recent Advances in Breast Cancer Care for Pregnant PatientsSibylle Loibl, André Schmidt, Oreste Gentilini, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2006
Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish populationSharon Simchoni, Eitan Friedman, Bella Kaufman, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2021
Efficacy and safety of first-line veliparib and carboplatin-paclitaxel in patients with HER2- advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trialBanu K Arun, Hyo S Han, Bella Kaufman, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 9, 2016
Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referralSari Lieberman, Ariela Tomer, Avi Ben-Chetrit, et al.
Fertility and Sterility|June 18, 2014
Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategiesDror Meirow, Hila Raanani, Ettie Maman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2016
Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast CancerMaya Dadiani, Noa Bossel Ben-Moshe, Shani Paluch-Shimon, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 20, 2019
Correction: Population screening for BRCA1/BRCA2 founder mutations in Ashkenazi Jews: proactive recruitment compared with self-referralSari Lieberman, Ariela Tomer, Avi Ben-Chetrit, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2014
Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutationBella Kaufman, Ronnie Shapira-Frommer, Rita K Schmutzler, et al.
Molecular Oncology|April 28, 2025
Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptationMaya Dadiani, Gilgi Friedlander, Gili Perry, et al.
Pageof 11